...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study
【24h】

The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study

机译:康迟尼亚的物理性能测量的价值在预测非小细胞肺癌中预测和完成中的预测和完成:观察探索性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The presence of muscle mass depletion is associated with poor outcomes and survival in cancer. Alongside muscle mass, assessment of muscle strength or physical performance is essential for the diagnosis of sarcopenia. Non-small cell lung cancer (NSCLC) is a prevalent form of cancer with high mortality, and Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is commonly used to assess patients' suitability for treatment. However, a significant proportion of patients with good PS are unable to complete multidisciplinary team (MDT)-planned treatment. Little is known about the ability of objective measurements of physical performance in predicting patients' ability to complete MDT-planned treatment and outcomes in NSCLC.
机译:肌肉质量耗竭的存在与癌症的差和生存率有关。 除了肌肉肿块,对肌肉力量或物理性能的评估对于疾病的诊断至关重要。 非小细胞肺癌(NSCLC)是一种普遍的癌症形式,具有高死亡率,而东方合作肿瘤组(ECOG)性能状况(PS)通常用于评估患者的治疗适宜性。 但是,良好PS患者的大量比例无法完成多学科团队(MDT)禁止治疗。 关于预测患者在NSCLC中完成MDT计划治疗和结果的患者的物理性能的客观测量能力很少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号